Illumina, Inc. (NASDAQ:ILMN – Get Free Report) CEO Jacob Thaysen acquired 7,330 shares of the company’s stock in a transaction on Thursday, February 22nd. The stock was acquired at an average cost of $135.29 per share, with a total value of $991,675.70. Following the completion of the purchase, the chief executive officer now directly owns […]
Natixis Advisors L.P. lessened its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 13.4% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 295,675 shares of the life sciences company’s stock after selling 45,801 shares during the quarter. […]
Natixis Advisors L.P. decreased its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 13.4% in the 3rd quarter, Holdings Channel.com reports. The fund owned 295,675 shares of the life sciences company’s stock after selling 45,801 shares during the quarter. Natixis Advisors L.P.’s holdings in Illumina were worth $40,591,000 as of its most recent SEC […]
CI Investments Inc. cut its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 11.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,559 shares of the life sciences company’s stock after selling 448 shares during the period. CI […]
StockNews.com upgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a hold rating to a buy rating in a research note published on Friday morning. Several other equities research analysts have also weighed in on ILMN. HSBC lowered Illumina from a buy rating to a hold rating in a report on Tuesday, January 16th. Guggenheim […]